Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...

Sometimes, I have the same nightmare: my last insulin pen breaks, and all the hospitals are closed ... blood sugar levels ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...

Diabetes management has come a long way, with treatment options now as varied as they are effective. No longer limited to ...

Belly fat, a concern for both appearance and health, can be tackled through sustainable lifestyle changes. Prioritizing a ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...